Heramed Ltd (HMD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -3.359x

Based on the latest financial reports, Heramed Ltd (HMD) has a cash flow conversion efficiency ratio of -3.359x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.27 Million ≈ $-901.06K USD) by net assets (AU$379.12K ≈ $268.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HMD defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Heramed Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Heramed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Heramed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heramed Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Progressive Planet Solutions Inc
V:PLAN
0.088x
Bumi Benowo Sukses Sejahtera Pt
JK:BBSS
-0.003x
Seni Jaya Corporation Bhd
KLSE:9431
0.128x
Hotel Fitra International Tbk PT
JK:FITT
-0.096x
Pelayaran Nelly Dwi Putri Tbk
JK:NELY
0.051x
Old Market Capital Corporation
NASDAQ:OMCC
-0.002x
Dynamic Group Holdings Ltd
AU:DDB
0.331x
Neuroone Medical Technologies Corp
NASDAQ:NMTC
-0.247x

Annual Cash Flow Conversion Efficiency for Heramed Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Heramed Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Heramed Ltd (HMD) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$1.72 Million
≈ $1.21 Million
AU$-4.81 Million
≈ $-3.41 Million
-2.807x +76.49%
2023-12-31 AU$466.70K
≈ $330.22K
AU$-5.57 Million
≈ $-3.94 Million
-11.940x -1249.49%
2022-12-31 AU$2.89 Million
≈ $2.05 Million
AU$-2.56 Million
≈ $-1.81 Million
-0.885x +87.90%
2021-12-31 AU$441.88K
≈ $312.66K
AU$-3.23 Million
≈ $-2.29 Million
-7.314x -422.60%
2020-12-31 AU$1.99 Million
≈ $1.41 Million
AU$-2.78 Million
≈ $-1.97 Million
-1.399x -21.16%
2019-12-31 AU$2.39 Million
≈ $1.69 Million
AU$-2.76 Million
≈ $-1.95 Million
-1.155x -183.85%
2018-12-31 AU$3.36 Million
≈ $2.37 Million
AU$-1.37 Million
≈ $-966.34K
-0.407x +85.05%
2017-12-31 AU$201.88K
≈ $142.84K
AU$-549.66K
≈ $-388.92K
-2.723x -71.31%
2016-12-31 AU$872.17K
≈ $617.12K
AU$-1.39 Million
≈ $-980.81K
-1.589x --

About Heramed Ltd

AU:HMD Australia Medical Devices
Market Cap
$28.37 Million
AU$40.09 Million AUD
Market Cap Rank
#23988 Global
#949 in Australia
Share Price
AU$0.04
Change (1 day)
-2.70%
52-Week Range
AU$0.01 - AU$0.05
All Time High
AU$0.32
About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more